Targeting eIF2alpha siRNA to alpha(v)beta(3) Integrin-bearing Tumor Cells
Targeting eIF2alpha siRNA to alpha(v)beta(3) Integrin-bearing Tumor Cells
批准号:
7980670
负责人:
CHING-AN PENG
金额:
$35.48万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2014-06-30
关键词:
AccountingApoptosisApoptoticBindingBinding SitesBiochemicalBiomedical EngineeringBlood CirculationBlood VesselsCD47 AntigenCD47 geneCell DeathCell LineCell SurvivalCellsChemical EngineeringChitosanDevelopmentDigestionDrug Delivery SystemsEducationEndothelial CellsEukaryotic Initiation FactorsEventExhibitsGenesGoalsHalf-LifeHandHourInduction of ApoptosisInflammationInflammatory ResponseIntegrin alphaVbeta3IntegrinsLigandsMembraneMolecular BiologyNatureNucleic AcidsOligonucleotidesPhagocytosisPlayProcessProtein BiosynthesisProtein SubunitsProtein Synthesis InductionProtein Synthesis InhibitionProteinsPublishingRNA SequencesRecruitment ActivityReportingResearchResearch PersonnelRoleSHPS-1 proteinSignal TransductionSiteSmall Interfering RNAStudentsSurfaceSystemTechniquesTertiary Protein StructureTestingTissuesTrainingTranslational RegulationVirus Activationangiogenesisbasecareerdesigngraduate studentin vivokillingsmacrophagemultidisciplinarynanomedicinenanovectorneoplastic cellneovasculaturenew growthnew technologyparticlepreventpublic health relevancetargeted deliverytumortumor growthuptakevector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): As a mode of cell death, apoptosis has an advantage in that it does not invoke an inflammatory response, thus there is decrease possibility of deleterious local and systemic events associated with tissue inflammation. Eukaryotic translation initiation factor eIF2? is chosen as a target because it is important in protein synthesis and is a central target of several types of translational regulation involving specific phosphorylation of this protein subunit of factor eIF2. Inhibition of protein synthesis contributes to cellular apoptosis and this process is often targeted by different viruses for the induction of apoptosis. In this proposed project, targeted delivery of apoptotic eIF2? siRNA to ?v?3 integrin-bearing tumor cells using polycationic chitosan as the vector will be studied. According to published accounts, shortened circulatory half-lives of oligonucleotide carriers in the bloodstream prevent sufficient oligonucleotides from reaching the target cells. To mitigate phagocytosis of eIF2? siRNA carriers, we propose to conjugate the "marker of self" integrin-associated protein (CD47) to chitosan-based siRNA carriers. In addition to its antiphagocytic feature, CD47 protein conjugated on siRNA nanovectors will act as a ligand targeted for tumor cells highly expressed with ?v?3 integrins. The proposed CD47-conjugated chitosan/siRNA nanovectors are expected to have much extended half-lives in blood circulation, hence allowing for more efficient site binding via ?v?3 integrin and eliciting apoptosis of tumor neovasculature by eIF2? siRNA. With regard to educational aspect of this project, the multidisciplinary nature of this project will produce students with training in biomedical engineering, molecular biology, gene/drug delivery, and nanomedicine. In addition to training graduate students, the educational plan of this project will recruit several undergraduates that are Chemical Engineering major with biochemical/biomedical emphasis and provide them with the opportunity of hands-on meritorious research. The undergraduate student researchers will actively participate in the development of new technology and explore their possible career path in biomedical fields.
PUBLIC HEALTH RELEVANCE: Eukaryotic translation initiation factor eIF2? is chosen as a target because it is important in protein synthesis. Since inhibition of protein synthesis contributes to cellular apoptosis, integrin-associated protein (CD47) conjugated eIF2? siRNA vectors are proposed to target tumor cells highly expressed with ?v?3 integrins and deliver apoptotic eIF2? siRNA.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.4155/tde.13.54
发表时间:
2013-07
期刊:
Therapeutic delivery
影响因子:
4.2
作者:
[Sawdon A, Peng CA]
通讯作者:
Peng CA
Polymeric micelles for acyclovir drug delivery.
用于阿昔洛韦药物递送的聚合物胶束。
DOI:
10.1016/j.colsurfb.2014.08.011
发表时间:
2014
期刊:
Colloids and surfaces. B, Biointerfaces
影响因子:
--
作者:
[Sawdon,AliciaJ, Peng,Ching-An]
通讯作者:
Peng,Ching-An
Retroviral Transduction Using Acoustic Waves
-
批准号:6922983
-
项目类别:
-
资助金额:$21.8万
-
财政年份:2005
-
负责人:CHING-AN PENG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: